Global Aptamers Market Outlook to 2023: Forecast to Grow at a CAGR of 19.9% - Analysis by Type, Application, End-User and Geography - ResearchAndMarkets.com
The "Global Aptamers Market - Forecasts from 2018 to 2023" report has been added to ResearchAndMarkets.com's offering.
The global aptamers market is expected to grow at a CAGR of 19.9% during the forecast period of 2017-2023.
The growth in the market may be attributed to the advantages of the aptamer over antibodies such as low cost and high efficiency, coupled with the diverse range of applications offered by the aptamers.
Continuous advancement in technologies along with its quick implementation is expected to boost the market growth during the given period.
However, lack of skilled professionals may hamper the market growth during the given period.
- DNA-based Aptamers
- RNA-based Aptamers
- Peptide-based Aptamers
- Pharmaceutical Companies
- Biotechnology Companies
- Research Institutes
- North America
- South America
- Middle East and Africa
- Asia Pacific
Key Topics Covered
2. Research Methodology
3. Key Findings of the Study
4. Market Dynamics
5. Global Aptamers Market Forecast by Type
6. Global Aptamers Market Forecast by Applications
7. Global Aptamers Market Forecast by End-Users
8. Global Aptamers Market Forecast by Geography
9. Competitive intelligence
10. Company Profiles
- Aptagen, LLC
- AMS Biotechnology (Europe) Limited
- Aptamer Group
- Elixin Pharma
- Base Pair Biotechnologies
- Serve Science Company Limited
- Aptus Biotech
- AM Biotech
For more information about this report visit https://www.researchandmarkets.com/research/rrsvl4/global_aptamers?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20181101005483/en/